Pembrolizumab as a first-line treatment for advanced gastric cancer

被引：1
|
作者：
Chau, Ian [1 ]
机构：
[1] Royal Marsden Hosp, Dept Med, Sutton, England
来源：
LANCET ONCOLOGY | 2023年 / 24卷 / 11期
关键词：
D O I：
10.1016/S1470-2045(23)00526-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1158 / 1159
页数：2
相关论文
共 50 条
  • [1] Pembrolizumab in the first-line treatment of advanced head and neck cancer
    de Sousa, Luana Guimaraes
    Ferrarotto, Renata
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (12) : 1321 - 1331
  • [2] Pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer
    Slater, Susanna
    Cunningham, David
    LANCET, 2023, 401 (10391): : 1826 - 1827
  • [3] Pembrolizumab in First-line Gastric Cancer: Win, Lose, or Draw?
    Smyth, Elizabeth C.
    Moehler, Markus
    JAMA ONCOLOGY, 2020, 6 (10) : 1539 - 1541
  • [4] FOLFIRI—improving toxicity in first-line treatment of advanced gastric cancer
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (12) : 684 - 684
  • [5] Pembrolizumab for first-line treatment of advanced unresectable or metastatic esophageal or gastroesophageal junction cancer
    Hirose, Toshiharu
    Yamamoto, Shun
    Kato, Ken
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [6] Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
    Wang, Guocheng
    Huang, Yan
    Zhou, Liang
    Yang, Haojun
    Lin, Huang
    Zhou, Shengfang
    Tan, Zhengang
    Qian, Jun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 198
  • [7] Advanced Esophageal Cancer: Pembrolizumab plus Chemotherapy as First-line Therapy
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (12): : 1255 - +
  • [8] Pembrolizumab plus chemotherapy for first-line treatment of advanced triple-negative breast cancer
    Haiderali, Amin
    Huang, Min
    Pan, Wilbur
    Akers, Katherine G.
    Maciel, Dylan
    Frederickson, Andrew M.
    FUTURE ONCOLOGY, 2024,
  • [9] Pembrolizumab plus Chemotherapy as First-Line Treatment in advanced Oesophageal Cancer (KEYNOTE-590)
    Hartmann, Milan
    Zander, Thomas
    Alakus, Hakan
    ONKOLOGE, 2022, 28 (05): : 436 - 437
  • [10] Weekly oral paclitaxel as first-line treatment in patients with advanced gastric cancer
    Kruijtzer, CMF
    Boot, H
    Beijnen, JH
    Lochs, HL
    Parnis, FX
    Planting, AST
    Pelgrims, JMG
    Williams, R
    Mathôt, RAA
    Rosing, H
    Schot, ME
    van Tinteren, H
    Schellens, JHM
    ANNALS OF ONCOLOGY, 2003, 14 (02) : 197 - 204
12345